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Copyright © 2010 JCBN Summary The present study attempted to clarify whether over-secretion of glucocorticoids in
the serum caused by increased hypothalamus-pituitary-adrenal activity induces oxidative
stress in the rat brain, and how the stress causes the emergence of cognitive deficits. When rats
were subcutaneously injected with corticosterone, lipid hydroperoxides and protein carbonyls
increased markedly in the hippocampus in association with a decrease in activity of antioxidative
enzymes, such as superoxide dismutase, catalase and glutathione peroxidase. These results
suggest that high-level corticosterone in the serum induces reactive oxygen species (ROS),
leading to oxidative damage in the hippocampus. After administration of corticosterone to
rats, glucose and superoxide levels in the serum increased markedly. Furthermore, pyramidal
cell apoptosis was observed to accompany the loss of glucocorticoid receptors at the cornus
ammonis 1 region of the hippocampus. Rats injected with corticosterone showed marked deficits
in memory function. The present results imply that ROS generated from the glycation reaction
of increased glucose levels caused by gluconeogenesis activation through glucocorticoid with
proteins in the serum attack the hippocampus to induce neurodegeneration, resulting in cognitive
deficits in rats.
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Introduction
Oxidative stress results from an imbalance between reac-
tive oxygen species (ROS) generation and detoxification by
antioxidants in living tissues, and neurodegeneration is
considered to be accumulation of oxidative damage to the
brain as a result of oxidative stress experienced over long
periods of time during aging [1, 2]. Among organs in living
tissues, neurons in the brain are considered to be more
vulnerable to oxidative stress, leading to neuronal oxidative
damage, and neurodegenerative disorders such as Alzheimer’s
disease (AD), Parkinsonism and senile dementia [3]. Recent
studies have demonstrated a decrease in polyunsaturated
fatty acids, and increased levels of lipid peroxidation
markers, protein oxidation, and DNA and RNA oxidation
in AD [4].
Based on the oxidative stress theory of neurodegenera-
tion, our previous work revealed that the levels of thiobarbi-
turic acid reactive substances (TBARS), lipid hydroper-
oxides (LOOH), F2-isoprostane and conjugated dienes
increase significantly in the rat brain through oxidative
stress, and the activity of antioxidative enzymes and vitamin
E content in the brain decrease markedly [5–7]. Furthermore,
in accordance with these phenomena, young rats subjected
to oxidative stress showed marked deficits in learning andInduction of Oxidative Stress Caused by Glucocorticoid
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memory functions. In addition to these phenomena, the
delayed-type apoptosis of pyramidal cells and the accumula-
tion of amyloid-β-like substances in the hippocampus of
young rats were induced by oxidative stress [8, 9]. These
abnormalities were also observed in both normal old rats
and vitamin E-deficient young rats not subjected to oxida-
tive stress. It is, therefore, reasonable to consider that
impairment in cognitive function caused by oxidative stress
during aging and in neurodegenerative disease results from
oxidative neuronal cell death.
It has been confirmed that there are increased regional
levels of oxidative stress in the AD brain, and hence,
oxidative stress is known to be involved in several neuro-
degenerative disorders characterized by progressive cogni-
tive deficits, and to induce dysfunction of the hypothalamus-
pituitary-adrenal (H-P-A) axis in AD, resulting in increased
corticoid levels in the serum and cerebrospinal fluid [10–12].
Glucocorticoids, which are steroid hormones secreted
through the H-P-A axis, play a major role in glucose
metabolism, anti-inflammation, growth processes, and neuro-
endocrine processes. The regulation of the H-P-A axis has
been classified as a negative feedback action. Hence, an
increase in the H-P-A activity is thought to be associated
with a decline in glucocorticoid negative feedback inhibition
over H-P-A activity [13]. This negative feedback is regu-
lated by glucocorticoid receptors (GRs) in hippocampal
pyramidal cells [14]. As hippocampal cell loss induces
increased plasma corticoid levels in AD, which leads to
further degenerative process [15], it is reasonable to suggest
that the decrease in negative feedback action due to loss of
GRs and H-P-A axis dysfunction arises from oxidative
stress. However, the causes of these phenomena in AD have
not been well understood.
Our recent results also revealed that young rats subjected
to hyperoxia showed hippocampal oxidative damage and
pyramidal cell apoptosis accompanied by a marked decrease
in GRs in hippocampal cornus ammonis 1 (CA1) region
[16]. Furthermore, it was found that oxidative stress induces
increase in secretion of corticotrophin-releasing hormone
in the hypothalamus, and plasma levels of adrenocortico-
trophic hormone and corticosterone [16]. Consequently, it
implies that oxidative stress induces oxidative damage in
the hippocampus and the H-P-A axis, resulting in cognitive
deficits in rats, and that negative feedback inhibition of
H-P-A activity was markedly dampened due to increased
corticosterone levels caused by loss of GRs. However, the
relevance of increased corticoid plasma levels to cognitive
deficits remains unclear. The present study aimed to verify
whether high level of glucocorticoids in the rat serum
induces oxidative stress, leading to cognitive deficits due




All animal experiments were performed with the approval
of the Animal Protection and Ethics Committee of the
Shibaura Institute of Technology. Male Wistar rats (age, 3
months; Japan SLC Co., Hamamatsu, Japan) were fed ad
libitum using standard diet and water. For biochemical
analysis and the behavior test, the same rats (n = 9 for each
group) were used.
Chemicals
Corticosterone, glucose analyzing kits (Glucose II Test
Wako, Osaka, Japan) and apoptosis detection kits were
purchased from Wako Pure Chemical Industries (Osaka,
Japan). Lucigenin for analysis of superoxide, isoluminol and
microperoxidase MP-11 were obtained from Sigma-Aldrich
Co. (St. Louis, MO). Rat GR antibody was purchased from
Thermo Fisher Scientific (Rockford, IL), and Elite ABC
kit-PK6101 were obtained from Vector Laboratories Inc.
(Burlingame, CA). All other chemicals were of the highest
grade available.
Corticosterone administration to rats
In order to reduce the influence of circadian changes in
rat physiological parameters, injection of corticosterone
was performed daily at 6 p.m. After learning trials were
conducted for 14 days, a suspension of corticosterone in
olive oil was subcutaneously injected in rats (0.5 mg/kg
body mass/day) for 14 days. Control rats were injected with
the same volume of olive oil alone for 14 days. During the
14-day injection period, trials continued to be conducted.
Analyses of oxidized components in hippocampus
After corticosterone treatment for 14 days, rats were
sacrificed, and brains were quickly removed, followed by
dissection of the hippocampus on ice. For analysis of
LOOH, tissues were extracted with a mixture of chloroform
and methanol (2:1, v/v). After evaporation of the extract,
residues were dissolved in 200 μl of methanol, and 80 μl of
this solution was mixed with a chemiluminescent solution
(mixture of 0.18 mg/ml isoluminol and 1 mg/ml micro-
peroxidase in 70% methanol, 100:1, v/v). Chemilumines-
cence of the solution was then analyzed using a Lumines-
cencer PSN apparatus (Atto Co., Tokyo, Japan), as described
previously [17]. Protein carbonyls, an index of protein
oxidation, were also analyzed. Homogenates of the hippo-
campus (100 μl) were incubated with a solution of 10 mM
2,4-dinitrophenyl hydrazine in 2 N HCl (400 μl) at 37°C for
60 min. This was mixed with a solution of 20% trichloro
acetic acid (500 μl), followed by incubation in an ice bath
for 10 min. After centrifugation at 3,000 rpm for 10 min at
4°C, the precipitate obtained was extracted with a mixtureH. Sato et al.
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of ethanol and ethyl acetate (1:1) to remove excess 2,4-
dinitrophenyl hydrazine. The precipitate was dissolved in
6 M guanidine solution (1 ml), and the optical density of the
clear solution obtained was measured at 365 nm.
Measurement of antioxidative enzyme activity
The activity of superoxide dismutase (SOD) in the super-
natant from aliquots of hippocampal homogenates was
analyzed based on the reduction of nitroblue tetrazolium
using the SOD analysis kit (Wako Pure Chemical Industries,
Osaka, Japan). The activities of catalase and glutathione
peroxidase were assessed as described previously [18, 19].
Detection of plasma levels of glucose and superoxide
Measurement of plasma glucose was performed by the
Mutarotase-Glucose oxidase method using a glucose kit, as
reported previously [20]. After 14 days of corticosterone
injections, serum (20 μl) was mixed well with 3 ml of a
solution from the kit, and incubated at 37°C for 5 min.
Samples were measured for absorbance at 505 nm. For
analysis of superoxide levels in the serum, 2.4 mM lucigenin
solution in 10 mM Tris-HCl buffer (500 μl) was added,
and the solution was diluted with 10 mM Tris-HCl buffer or
4 μM Fe(NO3)3 containing 10 mM Tris-HCl buffer (250 μl
each). After this mixture was placed in a chemiluminescence
detector, serum was added with stirring. Chemiluminescence
was then measured for 30 min at room temperature.
Tissue preparation for analysis of cell apoptosis and GR
levels in hippocampus
Removed brains were immediately immersed in Mizuhira’s
solution (3% paraformaldehyde in 0.1 M sodium cacodylate
buffer containing 0.1% tannic acid, 2 mM CaCl2 and 1 mM
MgCl2; pH 7.2–7.4) [21]. A microwave irradiation technique
was used for the rapid penetration of fixative solution.
Brains immersed in Mizuhira’s solution were exposed to
microwaves in a water bath for 30 s at 25°C. After irradia-
tion, samples were left to stand in fixative solution at room
temperature overnight. Frontal sections were then serially
sliced at 50 μm thickness using a microslicer (Vibratome,
Lancer, Bannockburn, IL).
Cell apoptosis and GR analyses
Cell damage and loss of hippocampal area were assessed
microscopically by hematoxylin-eosin staining. To visualize
DNA cleavage, we performed terminal deoxynucleotidyl
transferase (TdT)-mediated deoxyuridine triphosphate nick-
end labeling (TUNEL) using the apoptosis detection kit
(Wako Pure Chemical Industries, Ltd., Osaka, Japan), with
slight modification [22]. Briefly, to inactivate endogenous
peroxidase, sections were quenched with 2% H2O2 for
30 min at room temperature, and were then washed three
times for 5 min each with phosphate-buffered saline (PBS),
followed by incubation in terminal deoxynucleotidyl trans-
ferase buffer for 1 h at 37°C. Sections were washed again in
PBS and incubated in buffer with peroxidase-conjugated
antibodies for 30 min at room temperature. After washing
with PBS, they were developed with diaminobenzidine
and counterstained with methyl green. Changes in GRs in
the hippocampal area were assessed microscopically by
immunochemical staining using rat GR antibodies and Elite
ABC kit-PK6101. Positive antigen-antibody reactions were
visualized by incubating the slide in 250 μl of 0.3% 3,3'-
diaminobenzidine-terahydrochloride in 50 mM Tris-HCl
(pH 7.6) containing 3% H2O2. Negative staining was per-
formed using the same method, except that the GR antibody
was not used. Quantitative analysis of GRs was performed
in order to evaluate the intensity of stained GRs using an
imaging analyzer (LAS-3000; Fuji Film Co., Tokyo, Japan).
The intensity was analyzed by a deduction of the intensity
of background from that of the stained GRs.
Behavioral testing
Rats were tested for memory using a Morris water maze
apparatus (140 cm in diameter and 45 cm in height) [23].
The bottom of the pool was divided into quadrants using
white lines, and the transparent platform was submerged
2 cm below the surface of the water at the center of one of
the quadrants; the water was maintained at 21 ± 1°C. For
pre-training, the rats were allowed to swim freely in the pool
for 60 s without the platform. Daily training consisted of one
trial in which the rats swam from the start point to a fixed
goal; this was conducted for 14 consecutive days. After
learning the task, rats were injected with corticosterone.
During the 14-day injection period, trials continued to be
conducted. Thereafter, they were kept in an ordinary
atmosphere at 21 ± 1°C for 48 h without training to assess
their memory retention. Then the platform of the apparatus
was removed, and the rats were placed opposite the quadrant
where the platform had been located. The percentage of
time spent in the quadrant where the platform had been was
measured. This conducted for further 10 consecutive days.
Statistical analysis
Results are presented as means ± SE. All data were
analyzed by Student’s t test and one-way ANOVA, followed
by a Dunnett’s t test. Differences in experimental data
were considered to be statistically significant when p values
were less than 0.05.
Results
Changes in LOOH and oxidized protein, and activity of
antioxidative enzymes in hippocampus after corticosterone
injection
After injection of corticosterone, rats showed markedInduction of Oxidative Stress Caused by Glucocorticoid
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increases in levels of LOOH and oxidized protein by
approximately 2 and 3 times compared to controls, respec-
tively (Fig. 1(A) and (B)). These increases in the oxidized
components in hippocampus suggest that corticosterone
injection induces ROS, and hence, the hippocampus may be
damaged oxidatively by the ROS attack to increase such
oxidative components. To confirm this notion, the influence
of corticosterone on the activity of antioxidative enzymes in
the hippocampus was investigated. As shown in Fig. 2, the
activities of SOD, catalase and glutathione peroxidase
(GSHPx) in the hippocampus decreased markedly after
injection. Based on these results, it is considered that high
levels of corticosterone induce oxidative stress to induce
oxidative damage in the hippocampus caused by ROS.
Effect of corticosterone on the plasma glucose level
As corticoids are known to have anti-inflammatory effects
and to induce increases in blood sugar levels, the effects of
corticosterone on plasma glucose levels were investigated.
When rats were subcutaneously administered corticosterone,
they showed marked increases in plasma glucose levels at
14 days after injection (Fig. 3). Based on these results, it
is evident that corticosterone induced high glucose levels
in the serum through activated gluconeogenesis by corticos-
terone.
Corticosterone-induced generation of superoxide in serum
As it has been reported that human serum albumin and/or
polypeptides are glycated by glucose nonenzymatically in
Fig. 1. Increase in LOOH (A) and protein carbonyls (B) in the rat hippocampus caused by corticosterone injection. *p<0.01,
**p<0.005 vs normal control; means ± SE, n = 9 for each group of rats.
Fig. 2. Changes in SOD, catalase and glutathione peroxidase activities in the rat hippocampus caused by corticosterone injection. Open
columns, normal control; Closed columns, rats injected with corticosterone. *p<0.05, **p<0.001, #p<0.002 vs normal control;
means ± SE, n = 9 for each group of rats.H. Sato et al.
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vitro, followed by superoxide generation, and that genera-
tion of superoxide was accelerated by the presence of ferric
ions [24], the increased serum glucose levels in this study
most likely produced superoxide via glycation reactions
with serum protein of rats administered corticosterone. As
shown in Fig. 4, when rats were injected with corticosterone,
levels of superoxide in the serum increased markedly com-
pared to controls (Fig. 4, column B). Control sera mixed
with ferric ions showed high levels of superoxide (Fig. 4,
column C), but following addition of ferric ions to sera from
rats injected with corticosterone, superoxide levels were
more markedly increased (Fig. 4, column D). These results
indicate that increased glucose in the serum after corticos-
terone administration reacted nonenzymatically with serum
proteins via a glycation reaction to induce excess levels of
superoxide.
Appearance of apoptosis and changes in glucocorticoid
receptor (GR) levels after corticosterone injection
The superoxide generated leads to production of various
ROS, and may attack the brain to induce the oxidative
damage. This contention is supported by the previous
findings that oxidative stress induces ROS, followed by the
apoptosis of pyramidal cells in the hippocampus and the loss
of GRs [9, 16]. When rats were subcutaneously administered
corticosterone, pyramidal cell apoptosis was seen in the CA1
region of the hippocampus (Fig. 5(B)). In addition to cell
apoptosis, it was found that GR levels in the hippocampus
decreased markedly (Fig. 5(D) and (E)).
Influence of corticosterone injection on memory function
in rats
As pyramidal cell loss in the hippocampus, which
modulates memory function, was observed after injection of
corticosterone, we examined the influence of corticosterone
on memory function in rats. As shown in Fig. 6, control
rats mostly retained their memories of the platform location
throughout the experimented period. However, when rats
were injected with corticosterone, they retained their
memories for 4 days after resting for 48 h. However, their
memories suddenly declined beginning at 5 days after the
rest period. In the final test after administration of corticos-
terone, memory function decreased by 50–60%.
Discussion
Oxidative stress is elevated in the brains of subjects with
AD to induce pyramidal cell death in the hippocampus,
leading to loss of GRs. AD is also associated with high
serum levels of glucocorticoids and glucose [10–12]. Gluco-
corticoid levels are regulated by negative feedback in the
H-P-A axis via the GR response, and GR loss in AD patients
plays a role in activated H-P-A activity, resulting in over-
Fig. 3. Increase in serum glucose in rats after corticosterone
injection. *p<0.05 vs normal control; means ± SE, n =9
for each group of rats.
Fig. 4. Superoxide generation in rat serum caused by corticosterone injection. A, control; B, rats injected by corticosterone; C,
Fe(NO3)3-added A; D, Fe(NO3)3-added B. *p<0.05 vs A, **p<0.01 vs B; means ± SE, n = 9 for each group of rats.Induction of Oxidative Stress Caused by Glucocorticoid
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secretion of glucocorticoids. However, the relationship
between these abnormalities and cognitive impairment in
AD is poorly understood. As AD patients treated with
prednisone, which is a glucocorticoid used as an anti-
inflammatory agent, show impaired cognition when com-
pared with placebo-treated patients, glucocorticoids are
thought to have a detrimental role in AD [12]. However, the
role of glucocorticoids in cognitive impairment through
neurodegeneration is unclear.
In order to clarify whether over-secretion of gluco-
corticoids caused by increased H-P-A activity induces
oxidative stress to injure the brain, and how this may be
involved in the emergence of cognitive deficits, we investi-
gated the influence of glucocorticoids on oxidative brain
damage using young normal rats injected subcutaneously
with corticosterone. As shown in Fig. 1(A) and (B), when
rats were administered corticosterone, LOOH and oxidized
protein increased markedly in the hippocampus when
compared to control rats. As both compounds are known to
be oxidation products of lipids and proteins, it was evident
Fig. 5. Pyramidal cell apoptosis (B) and GR loss (D) and (E) in CA1 region in rat hippocampus. (A) and (C), normal controls; (B) and (D),
rats injected with corticosterone; Arrowhead in (B) shows apoptotic cells in CA1 region, and that in (C) shows immunochemically
stained GR in pyramidal cells. Magnification for each photograph is indicated by the bars in (B) and (D). *p<0.05 vs normal
control.H. Sato et al.
J. Clin. Biochem. Nutr.
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that glucocorticoid induced oxidative stress to generate
ROS in the rat brain. Based on these results, changes in the
activity of antioxidant enzymes, such as SOD, catalase and
GSHPx, were analyzed in the rat hippocampus. Although
mRNA levels of these antioxidant enzymes were not
analyzed in this study, it is considered that the activities of
these enzymes might be markedly decreased for scavenging
of ROS without further production of these enzymes (Fig. 2).
These results suggest that glucocorticoids may damage
the hippocampus by generating ROS. To confirm this
notion, immunochemical analysis of the hippocampus was
performed by TUNEL. As shown in Fig. 5(B), pyramidal
cell apoptosis was found in the CA1 region of the rat
hippocampus. Consequently, it appears that the ROS
generated by corticosterone attacked the hippocampus to
damage the pyramidal cells, resulting in neuronal cell
apoptosis.
It is widely recognized that glucocorticoids have a role in
both anti-inflammation and gluconeogenesis activation.
Hence, the high glucocorticoid levels in this study would
be expected to produce elevated glucose levels in the serum
based on the effects of gluconeogenesis activation. As
shown in Fig. 3, when rats were administered corticosterone,
serum glucose levels increased markedly. It is known that
lysine residues in serum proteins are glycated by glucose to
induce superoxide in the presence of ferric ions (Fig. 7) [24].
The link between glucocorticoid and ROS generation
remains poorly understood, and hence, the probability of
superoxide generation due to high glucose levels after
corticosterone administration was investigated. Superoxide
generation increased markedly following the injection of
corticosterone (Fig. 4, column B). When ferric ions were
added to the serum of rats injected with corticosterone,
superoxide generation was further increased significantly
(Fig. 4, column D). When ferric ions were added to control
serum, superoxide generation was also increased (Fig. 4,
column C).
The fact obtained here that higher superoxide levels were
observed in the serum added by ferric ions may show the
probability of superoxide generation due to the reaction of
glycated proteins with ferric ions. However, it is unclear at
the present day whether glycated proteins in the rat serum
were actually produced, and reacted with ferric ions to
induce superoxide. In order to verify this notion, further
investigations are necessarily needed.
Thus, it can imply that ROS arising from superoxide
generated by glucocorticoids attack the hippocampus to
induce oxidative damage, resulting in the pyramidal cell
apoptosis.
As negative feedback via H-P-A activity is regulated by
GRs in hippocampal pyramidal cells [14], the hippocampal
cell loss observed here (Fig. 5(B)) may induce decreases in
GR levels in the hippocampus, leading to over-secretion of
corticosterone. To confirm this notion, changes in GRs in
the hippocampal area were assessed microscopically by
immunochemical staining using rat GR antibodies. As shown
in Fig. 5(D) and (E), GR levels in the CA1 region in the
hippocampus decreased markedly. Therefore, ROS generated
by serum protein glycation must have attacked pyramidal
cells in the hippocampus to induce GR loss, leading to an
increase in H-P-A activity and, ultimately, over-secretion of
glucocorticoids.
The results obtained in this study prompted us to assess
the memory function of rats injected with corticosterone.
After rats learned the location of the platform in the pool,
the influence of corticosterone on memory function was
assessed. Control rats retained their memory function
throughout the experimental period. When rats were sub-
cutaneously injected with corticosterone, they retained their
memories within four days after resting. However, their
Fig. 6. Changes in memory retention in rats after corticosterone injection. Open circles, control rats; closed circles, rats injected with
corticosterone. Arrowhead shows endpoint of rest without trial, and “−2 days” indicates the start point of resting. *p<0.01,
**p<0.05 vs normal control; means ± SE, n = 9 for each group of rats.Induction of Oxidative Stress Caused by Glucocorticoid
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memories began to decrease five days after resting (Fig. 6).
Thus, it is evident that the oxidative pyramidal cell loss
caused by increased serum glucocorticoid induces impair-
ment of memory function in rats.
In conclusion, when rats are subjected to oxidative stress,
serious damage to pyramidal cells induce an increase in
H-P-A activity, leading to over-secretion of corticosterone
[16]. Increased serum corticosterone may induce ROS
through glycation of serum protein, and the hippocampus
is further damaged oxidatively. After H-P-A function is
damaged by the oxidative stress, this process may be
exaggerated through increased glucocorticoid production,
and cognitive functions are ultimately impaired. Thus, it
implies that over-secretion of glucocorticoids caused by
oxidative stress further induce oxidative stress to damage
hippocampal cells. It has been reported that glucocorticoid
enhances cell death in cultured hippocampal cells after
amyloid β protein and glutamate challenge in vitro [25]. Our
in vivo data may explain the cause of these findings, and
suggest a link between activated H-P-A activity and cogni-
tive impairment in AD.
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